IL161966A0 - Aryloxyphenyl and arylsulfanylphenyl - Google Patents
Aryloxyphenyl and arylsulfanylphenylInfo
- Publication number
- IL161966A0 IL161966A0 IL16196602A IL16196602A IL161966A0 IL 161966 A0 IL161966 A0 IL 161966A0 IL 16196602 A IL16196602 A IL 16196602A IL 16196602 A IL16196602 A IL 16196602A IL 161966 A0 IL161966 A0 IL 161966A0
- Authority
- IL
- Israel
- Prior art keywords
- arylsulfanylphenyl
- aryloxyphenyl
- compounds
- valuable
- substituents
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34265301P | 2001-12-20 | 2001-12-20 | |
| DKPA200101927 | 2001-12-20 | ||
| PCT/DK2002/000859 WO2003053942A1 (en) | 2001-12-20 | 2002-12-16 | Aryloxyphenyl and arylsulfanylphenyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161966A0 true IL161966A0 (en) | 2005-11-20 |
Family
ID=26069114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16196602A IL161966A0 (en) | 2001-12-20 | 2002-12-16 | Aryloxyphenyl and arylsulfanylphenyl |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7067501B2 (no) |
| EP (1) | EP1458689B1 (no) |
| JP (1) | JP2005513128A (no) |
| CN (1) | CN100457738C (no) |
| AT (1) | ATE359276T1 (no) |
| AU (1) | AU2002351734A1 (no) |
| CA (1) | CA2467118A1 (no) |
| DE (1) | DE60219521T2 (no) |
| ES (1) | ES2280595T3 (no) |
| HU (1) | HUP0402320A2 (no) |
| IL (1) | IL161966A0 (no) |
| IS (1) | IS7258A (no) |
| MX (1) | MXPA04005989A (no) |
| NO (1) | NO20042885L (no) |
| WO (1) | WO2003053942A1 (no) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| KR20060066729A (ko) * | 2003-08-21 | 2006-06-16 | 하. 룬트벡 아크티에 셀스카브 | 우울증 치료를 위한 세로토닌 재흡수 억제제 및 글리신트랜스포터 타입 1 억제제의 조합 |
| WO2005058885A2 (en) * | 2003-12-18 | 2005-06-30 | Glaxo Group Limited | Piperidine derivatives and their use as glycine transporter inhibitors |
| WO2005058317A1 (en) * | 2003-12-18 | 2005-06-30 | Glaxo Group Limited | Glycine transporter-1 inhibirors |
| BRPI0418374A (pt) * | 2004-01-08 | 2007-05-22 | Hoffmann La Roche | derivados de diaza-espiropiperidina como inibidores de transportador 1 de glicina e transportador 2 de glicina |
| WO2006000222A2 (en) * | 2004-06-24 | 2006-01-05 | H. Lundbeck A/S | The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia |
| US7485637B2 (en) * | 2005-01-04 | 2009-02-03 | Hoffmann-La Roche Inc. | Benzoyl-tetrahydropiperidine derivatives |
| KR101627901B1 (ko) | 2006-06-16 | 2016-06-13 | 하. 룬트벡 아크티에 셀스카브 | 인지기능 장애의 치료를 위한, 세로토닌 재흡수, 5-ht3 및 5-ht1a 활성이 조합된 화합물로서의 1-[2-(2,4-디메틸페닐술파닐)-페닐]피페라진 |
| SG172685A1 (en) * | 2006-06-28 | 2011-07-28 | Amgen Inc | Glycine transporter-1 inhibitors |
| TW200848411A (en) * | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
| EP2178842A2 (en) | 2007-08-22 | 2010-04-28 | Abbott GmbH & Co. KG | 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| TW200932233A (en) * | 2007-11-13 | 2009-08-01 | Lundbeck & Co As H | Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity |
| WO2009075857A2 (en) * | 2007-12-12 | 2009-06-18 | Amgen Inc. | Glycine transporter-1 inhibitors |
| ES2397764T3 (es) | 2008-04-01 | 2013-03-11 | Abbott Gmbh & Co. Kg | Tetrahidroisoquinolinas, composiciones farmacéuticas que las contienen, y su uso en terapia |
| TW201038569A (en) | 2009-02-16 | 2010-11-01 | Abbott Gmbh & Co Kg | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
| AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
| EP2539706B1 (en) * | 2010-02-24 | 2015-03-04 | Research Triangle Institute | Arylpiperazine opioid receptor antagonists |
| US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| JP2014521682A (ja) | 2011-08-05 | 2014-08-28 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノクロマン、アミノチオクロマンおよびアミノ−１，２，３，４−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用 |
| EP2780328A1 (en) | 2011-11-18 | 2014-09-24 | Abbvie Deutschland GmbH & Co. KG | N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| DK2800746T3 (da) * | 2012-01-03 | 2019-05-20 | H Lundbeck As | Fremgangsmåde til fremstilling af 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazin |
| US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| ME02671B (me) * | 2013-02-22 | 2017-06-20 | H Lundbeck As | Postupak za proizvodnju vortioksetina |
| US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| MX2016004936A (es) | 2013-10-17 | 2016-12-20 | Abbvie Deutschland | Derivados de aminocromano, aminotiocromano y amino-1,2,3,4-tetrahi droquinilina, composiciones farmaceuticas que los contienen, y su uso en terapia. |
| WO2015055771A1 (en) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
| KR101753617B1 (ko) | 2016-05-10 | 2017-07-11 | 주식회사 뉴로벤티 | 피페라진-1-카복사미딘 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 자폐 범주성 장애 예방 및 치료용 약학적 조성물 |
| US10927089B2 (en) | 2016-06-16 | 2021-02-23 | Sunshine Lake Pharma Co., Ltd. | Diaryl thioether piperazine compounds, preparation methods and uses thereof |
| CN106279071B (zh) * | 2016-08-10 | 2019-01-04 | 广东东阳光药业有限公司 | 苯基哌嗪衍生物及其使用方法和用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5730738A (en) | 1995-12-04 | 1998-03-24 | The Procter & Gamble Company | Absorbent article with angled band structural elastic-like film cuffs |
| JPH10152470A (ja) * | 1996-09-25 | 1998-06-09 | Yoshitomi Pharmaceut Ind Ltd | ピペラジン化合物 |
| NZ334868A (en) * | 1996-10-21 | 2001-02-23 | Neurosearch As | 1-Phenyl-benzimidazole compounds and their use as BAGA-a receptor modulators |
| KR20060066729A (ko) * | 2003-08-21 | 2006-06-16 | 하. 룬트벡 아크티에 셀스카브 | 우울증 치료를 위한 세로토닌 재흡수 억제제 및 글리신트랜스포터 타입 1 억제제의 조합 |
-
2002
- 2002-12-16 CN CNB028257022A patent/CN100457738C/zh not_active Expired - Fee Related
- 2002-12-16 IL IL16196602A patent/IL161966A0/xx unknown
- 2002-12-16 EP EP02787451A patent/EP1458689B1/en not_active Expired - Lifetime
- 2002-12-16 CA CA002467118A patent/CA2467118A1/en not_active Abandoned
- 2002-12-16 WO PCT/DK2002/000859 patent/WO2003053942A1/en not_active Ceased
- 2002-12-16 AT AT02787451T patent/ATE359276T1/de not_active IP Right Cessation
- 2002-12-16 MX MXPA04005989A patent/MXPA04005989A/es unknown
- 2002-12-16 DE DE60219521T patent/DE60219521T2/de not_active Expired - Fee Related
- 2002-12-16 JP JP2003554658A patent/JP2005513128A/ja active Pending
- 2002-12-16 AU AU2002351734A patent/AU2002351734A1/en not_active Abandoned
- 2002-12-16 ES ES02787451T patent/ES2280595T3/es not_active Expired - Lifetime
- 2002-12-16 HU HU0402320A patent/HUP0402320A2/hu unknown
-
2004
- 2004-05-10 IS IS7258A patent/IS7258A/is unknown
- 2004-05-20 US US10/851,769 patent/US7067501B2/en not_active Expired - Fee Related
- 2004-07-07 NO NO20042885A patent/NO20042885L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60219521D1 (de) | 2007-05-24 |
| HUP0402320A2 (hu) | 2005-03-29 |
| CN1606548A (zh) | 2005-04-13 |
| EP1458689B1 (en) | 2007-04-11 |
| IS7258A (is) | 2004-05-10 |
| WO2003053942A1 (en) | 2003-07-03 |
| ES2280595T3 (es) | 2007-09-16 |
| NO20042885L (no) | 2004-07-07 |
| CN100457738C (zh) | 2009-02-04 |
| HK1076807A1 (zh) | 2006-01-27 |
| AU2002351734A1 (en) | 2003-07-09 |
| US20050171061A1 (en) | 2005-08-04 |
| EP1458689A1 (en) | 2004-09-22 |
| MXPA04005989A (es) | 2004-09-27 |
| CA2467118A1 (en) | 2003-07-03 |
| JP2005513128A (ja) | 2005-05-12 |
| DE60219521T2 (de) | 2007-08-16 |
| US7067501B2 (en) | 2006-06-27 |
| ATE359276T1 (de) | 2007-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042885L (no) | Aryloksyfenyl- og arylsulfanylfenylderivater | |
| PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
| PL369530A1 (en) | Chemical compounds | |
| IL163777A0 (en) | Kinase inhibitors | |
| CY1109006T1 (el) | Παραγωγα πουρινης ως αναστολεις κινασης | |
| ZA200704910B (en) | Pyrrolidine inhibitors of IAP | |
| GEP20105081B (en) | Pyrrolotriazine compounds as kinase inhibitors | |
| TW200640924A (en) | VEGF-R2 inhibitors and methods | |
| GB0130341D0 (en) | Compounds | |
| MY130718A (en) | Antitumor compounds and methods | |
| CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
| GEP20074215B (en) | Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof | |
| MY133969A (en) | Indoloquinazolinones | |
| ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
| MXPA04006266A (es) | Pirimidotriazinas como inhibidores de fosfatasa. | |
| AU2003290592A1 (en) | Antitumor benzoylsulfonamides | |
| SE0103710D0 (sv) | Compounds | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| DE60204701D1 (de) | Tricyclische imidazopyridine | |
| UA85505C2 (en) | Kinase inhibitors | |
| EA201270630A1 (ru) | Гетероциклические сетр ингибиторы | |
| MY128164A (en) | Compounds | |
| SI1377574T1 (no) | ||
| MXPA06003345A (es) | Derivados de aminopiridina como inhibidores de la no-sintasa inducible. | |
| MXPA06000372A (es) | Compuestos de silicio y su uso. |